News11 hours ago
InProTher Announces EUR 6M Seed Financing with the Participation of the European Innovation Council Fund to Develop First-In-Class Cancer Immunotherapy
Danish start-up developing immunotherapies designed to fight the tumors from within Financing supports GMP and toxicology studies and will advance InProTher’s first-in-class cancer immunotherapy into First-in-Human...
